Abstract
Infectious complications are a significant cause of morbidity and mortality in kidney transplant recipients and remain the second leading cause of mortality in kidney transplant recipients. Fungal infections comprise about 10% of the overall infections, but their mortality is extremely high, thus the clinician must have a high index of suspicion for fungal infections in kidney transplant patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pérez-Sáez MJ, Mir M, Montero MM, Crespo M, Montero N, Gómez J, Horcajada JP, Pascual J. Invasive aspergillosis in kidney transplant recipients: a cohort study. Exp Clin Transplant. 2014;12(2):101–5.
Nampoory MR, Khan ZU, Johny KV, et al. Invasive fungal infections in renal transplant recipients. J Infect. 1996;33(2):95–101.
Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M. Fungal infections in solid organ recipients. Exp Clin Transplant. 2005;3(2):385–9.
Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transpl. 2006;20(4):401–9.
Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol. 2005;43(Suppl. 1):S49–58.
Bodro M, Sabé N, Gomila A, et al. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplant Proc. 2012;44(9):2682–5.
Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, Naoe S, Okudaira M, Scevola D, van’t Wout J. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis. 1992;11:99–109.
Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358–66.
Sonneville R, Magalhaes E, Meyfroidt G. Central nervous system infections in immunocompromised patients. Curr Opin Crit Care. 2017 Apr;23(2):128–33.
Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol. 2004;83(Suppl. 1):S42–4.
Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, Schuler U, Lutsar I, Troke P, Thiel E. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 2005;106(8):2641–5.
Coleman JM, Hogg GG, Rosenfeld JV, Waters KD. Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery–case report and review of the literature. Neurosurgery. 1995;36:858–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Joachim, E., Hindi, J. (2022). Central Nervous System Aspergillosis in a Kidney Transplant Recipient. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_25
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)